GT Biopharma (GTBP) Non Operating Investment Income (2019 - 2024)
GT Biopharma (GTBP) recorded Non Operating Investment Income of $2,000 in Q3 2024, down 60.0% from $5,000 a year earlier but up 100.0% from the prior quarter.
Powered by 
Analysis
GT Biopharma (GTBP) Non Operating Investment Income (2019 - 2024) Analysis & Trends
On a TTM basis, GT Biopharma's Non Operating Investment Income came in at $6,000 as of Sep 30, 2024, down 90.9% year-over-year; for FY2023, it came in at $48,000.
- Annual Non Operating Investment Income has a four-year compound annual growth rate of -78.0% (FY2019 to FY2023).
- Across earlier years, Non Operating Investment Income came in at -$30,000 in FY2022, -$29,000 in FY2021 and $20.46 million in FY2019.
- Quarterly Non Operating Investment Income has ranged from -$33,000 in Q3 2021 to $40.96 million in Q4 2019 over the past five years.
- On a year-over-year basis, Non Operating Investment Income rose in 1 of the last four quarters, with growth averaging 62.0%.
- Per Business Quant, the preceding three quarters came in at $1,000 (Q2 2024), -$2,000 (Q1 2024) and $5,000 (Q4 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Op. Investment Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | GT Biopharma | 8.58 Mn | 8.58 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Jun 30, 2023 | 9,000.00 |
| Mar 31, 2023 | 29,000.00 |
| Dec 31, 2022 | 23,000.00 |
| Sep 30, 2022 | -23,000.00 |
| Jun 30, 2022 | -6,000.00 |
| Mar 31, 2022 | -24,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | -33,000.00 |
| Dec 31, 2019 | 40.96 Mn |
| Sep 30, 2019 | -20.46 Mn |
| Jun 30, 2019 | -31,000.00 |
API Access
GT Biopharma Non Operating Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();